0001144204-11-030002.txt : 20110516
0001144204-11-030002.hdr.sgml : 20110516
20110516161033
ACCESSION NUMBER: 0001144204-11-030002
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110331
FILED AS OF DATE: 20110516
DATE AS OF CHANGE: 20110516
EFFECTIVENESS DATE: 20110516
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001346824
IRS NUMBER: 830406777
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12884
FILM NUMBER: 11846924
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 905
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 905
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
v222838_13fhr.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2011
Check here if Amendment [_]; Amendment Number: ___________
This Amendment (Check only one): [_] is a restatement.
[_] adds new entries.
Institutional Investment Manager Filing this Report:
Name: RA Capital Management, LLC
-------------------------------------
Address: 20 Park Plaza, Suite 905
-------------------------------------
Boston, MA 02116
-------------------------------------
Form 13F File Number: 28-12884
--------
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Peter Kolchinsky
-------------------------------------
Title: Manager
-------------------------------------
Phone: (617) 778-2500
-------------------------------------
Signature, Place, and Date of Signing
/s/ Peter Kolchinsky Boston, MA May 16, 2011
-------------------------- -------------------------- ----------------------
[Signature] [City, State] [Date]
Report Type (Check only one):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
List of Other Managers Reporting for this Manager: NONE
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
-----------------
Form 13F Information Tabel Entry Total: 27
-----------------
Form 13F Information Table Value Total: 151,197
-----------------
(thousands)
List of Other Included Managers: NONE
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
--------------------------- ------------ ----------- -------- ---------------------- ---------- -------- ---------------------
TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE/ SHARED/NONE
------------------------------------------------------------------------------------------------------------------------------------
ACADIA PHARMACEUTICALS INC COM 004225 10 8 8,381 5,173,708 SH SOLE N/A 5,173,708
ADVENTRX PHARMACEUTICALS INC COM NEW 00764X 20 2 4,967 2,365,000 SH SOLE N/A 2,365,000
AFFYMAX INC COM 00826A 10 9 9,814 1,671,908 SH SOLE N/A 1,671,908
ALEXION PHARMACEUTICALS INC COM 015351 10 9 9,972 101,050 SH SOLE N/A 101,050
ARQULE INC COM 04269E 10 7 814 114,074 SH SOLE N/A 114,074
ARTHROCARE CORP COM 043136 10 0 9,679 290,319 SH SOLE N/A 290,319
BIOSPECIFICS TECHNOLOGIES CO COM 090931 10 6 5,976 234,362 SH SOLE N/A 234,362
COLUMBIA LABS INC COM 197779 10 1 4,057 1,076,116 SH SOLE N/A 1,076,116
DERMA SCIENCES INC COM PAR $.01 249827 50 2 436 44,940 SH SOLE N/A 44,940
DISCOVERY LABORATORIES INC N COM NEW 254668 40 3 1,064 575,000 SH SOLE N/A 575,000
DYNAVAX TECHNOLOGIES CORP COM 268158 10 2 6,047 2,191,071 SH SOLE N/A 2,191,071
ENDOCYTE INC COM 29269A 10 2 2,049 239,100 SH SOLE N/A 239,100
ENZO BIOCHEM INC COM 294100 10 2 787 187,900 SH SOLE N/A 187,900
GILEAD SCIENCES INC COM 375558 10 3 8,069 190,000 SH SOLE N/A 190,000
INHIBITEX INC COM 45719T 10 3 1,090 301,200 SH SOLE N/A 301,200
JAZZ PHARMACEUTICALS INC COM 472147 10 7 6,861 215,424 SH SOLE N/A 215,424
MAXYGEN INC COM 577776 10 7 926 178,015 SH SOLE N/A 178,015
ONCOGENEX PHARMACEUTICALS IN COM 68230A 10 6 8,082 528,255 SH SOLE N/A 528,255
ONCOTHYREON INC COM 682324 10 8 916 236,739 SH SOLE N/A 236,739
OPKO HEALTH INC COM 68375N 10 3 560 150,000 SH SOLE N/A 150,000
PHARMASSET INC COM 71715N 10 6 11,630 147,761 SH SOLE N/A 147,761
REPLIGEN CORP COM 759916 10 9 3,328 889,741 SH SOLE N/A 889,741
SEQUENOM INC COM NEW 817337 40 5 15,615 2,462,879 SH SOLE N/A 2,462,879
TARGACEPT INC COM 87611R 30 6 10,714 402,938 SH SOLE N/A 402,938
TENGION INC COM 88034G 10 9 2,640 1,060,070 SH SOLE N/A 1,060,070
UNITED THERAPEUTICS CORP DEL COM 91307C 10 2 6,906 103,050 SH SOLE N/A 211,500
VALEANT PHARMACEUTICALS INTL COM 91911K 10 2 10,535 211,500 SH SOLE N/A 211,500